Publications by authors named "Vivekanand Jha"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

7,961

Total Likes

1,262

Extended Reach

3,351,616

Social Features

479
P
Potassium-Enriched Salt Substitutes: A Review of Recommendations in Clinical Management Guidelines.
Xiaoyue Xu, Ling Zeng, Vivekanand Jha, Laura K Cobb, Kenji Shibuya, Lawrence J Appel, Bruce Neal, Aletta E Schutte

Hypertension· March 2024

Videos about Article: user user user

3 2 53 4 84

View All Article and Social Media Activity
E
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
Jicheng Lv, Muh Geot Wong, Michelle A Hladunewich, Vivekanand Jha, Lai Seong Hooi, Helen Monaghan, Minghui Zhao, Sean Barbour, Meg J Jardine, Heather N Reich

May 2022

Videos about Article: user user user

3 1 2 257 6 18

View All Article and Social Media Activity
D
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
Ajay K Singh, Kevin Carroll, Vlado Perkovic, Scott Solomon, Vivekanand Jha, Kirsten L Johansen, Renato D Lopes, Iain C Macdougall, Gregorio T Obrador, Sushrut S Waikar

N Engl J Med· December 2021

Videos about Article: user user

2 1 49 2 16

View All Article and Social Media Activity
T
The Novel Coronavirus 2019 epidemic and kidneys.
Saraladevi Naicker, Chih-Wei Yang, Shang-Jyh Hwang, Bi-Cheng Liu, Jiang-Hua Chen, Vivekanand Jha

May 2020

Videos about Article: user user

2 14 108 5 42

View All Article and Social Media Activity
S
Slowing of progress in reducing non-communicable disease mortality.
Vivekanand Jha

Nat Rev Nephrol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Colchicine for the Treatment of Long COVID: A Randomized Clinical Trial.
Abhinav Bassi, Niveditha Devasenapathy, Shani S Thankachen, Arpita Ghosh, Aman Rastogi, Vivekanand Jha

JAMA Intern Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convalescent plasma in hospitalised patients with COVID-19.
Zoe McQuilten, Matthew V N O'Sullivan, Damien Purcell, Peta Edler, Niamh Meagher, Vivekanand Jha

Intern Med J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to integrate climate science into kidney care planning: a 'PASIGE' to a climate change mitigation and adaptation framework.
Shaifali Sandal, Vivekanand Jha

Curr Opin Nephrol Hypertens· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy.
Richard Lafayette, Sean J Barbour, Robert M Brenner, Kirk N Campbell, Tom Doan, Vivekanand Jha

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.
Vlado Perkovic, Hernán Trimarchi, Vladimir Tesar, Richard Lafayette, Muh Geot Wong, Vivekanand Jha

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmenting nephroprotection: balcinrenone plus dapagliflozin in chronic kidney disease.
Vivekanand Jha

Lancet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Including Kidney Health in the National Public Health Agenda: The Time is Now.
Sumana Vasishta, Vivekanand Jha

J Assoc Physicians India· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Controlled Trial on the Efficacy of Reduced-Dose Cyclical Corticosteroids and Cyclophosphamide in Primary Membranous Nephropathy.
Raja Ramachandran, Prabhat Chauhan, Joyita Bharati, Manisha Sahay, Indranil Ghosh, Vivekanand Jha

Kidney Int Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaling Up Peritoneal Dialysis in India: A Sustainability Perspective Using the Program Sustainability Assessment Tool.
Vivekanand Jha, Arpana Iyengar, Vijay Kher, Sandeep Mahajan, Narayan Prasad

Kidney Int Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cocreation of Integrated Interventions Addressing Noncommunicable Diseases and Environmental Degradation: Protocol for a Participatory Qualitative Study.
Nushrat Khan, Paraskevi Seferidi, Kristine Belesova, Nantu Chakma, Laura Downey, Vivekanand Jha

JMIR Res Protoc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing alkali assisted leaf as phytosorbent for removal of crystal violet from water.
Priyanka Yadav, Rachana, Vivekanand Jha, Divyanshu, Sudhir G Warkar

Int J Phytoremediation· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indications and recent evidence for apheresis in children and adults with kidney diseases: a comprehensive review.
Rupesh Raina, Eugene Yu-Hin Chan, Jieji Hu, Pujan Moradiya, Bryce Pember, Vivekanand Jha

Clin Kidney J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary effectiveness and feasibility of ASHA-led mobile health intervention for diabetes care in Indian primary health care settings.
Abhinav Bassi, Varun Arora, Sumaiya Arfin, Oommen John, Kavita Yadav, Vivekanand Jha

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"" Multinational-Microsimulation Modelling Insights Into the Increasing CKD Burden.
Jay Wish, Saeed Mg Al-Ghamdi, Jean-Michel Halimi, Michel Jadoul, Vivekanand Jha

Kidney Int Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex Differences Across Corticosteroid Response and Outcomes in IgA Nephropathy.
Dana Kim, Mark Woodward, Jicheng Lv, Michelle A Hladunewich, Vivekanand Jha

Kidney Int Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab, Cyclophosphamide, and Corticosteroid Combination in Difficult-to-Treat Membranous Nephropathy.
Arun Prabhahar, Niranjan Anitha Vijayakumar, Joyita Bharati, Sushma Rani, Vinod Kumar, Vivekanand Jha

Indian J Nephrol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and Design of the International Prospective Study of CKD of Uncertain Etiology in Agricultural Communities.
Jill F Lebov, Daniel R Brooks, Anna Aceituno, Hildaura Acosta, Juan Amador Velázquez, Vivekanand Jha

Kidney Int Rep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Diagnostic Disparities in Kidney Disease: A Call to Action.
Mythri Shankar, Becky Mingyao Ma, Marek Kollar, Ana Catalina Alvarez-Elias, Carmen Elena Cervantes, Vivekanand Jha

Kidney Int Rep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline.
Arnav Agarwal, Reem Mustafa, Veena Manja, Thomas Agoritsas, Helen Macdonald, Vivekanand Jha

BMJ· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial.
Michael Walsh, David Collister, Martin Gallagher, Patrick B Mark, Janak R de Zoysa, Vivekanand Jha

Lancet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.
Kitty St Pierre, Ragada El-Damanawi, David W Johnson, Carmel M Hawley, Andrea K Viecelli, Vivekanand Jha

Trials· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of impaired kidney function & its association with diabetes & hypertension in India: The ICMR-INDIAB study (ICMR-INDIAB-22).
Rajendra Pradeepa, Mohan Deepa, Ulagamathesan Venkatesan, Paturi Vishnupriya Rao, Ajay Kumar, Vivekanand Jha

Indian J Med Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts" [ Volume 10, Issue 4, April 2025, Pages 1283-1287].
Sean J Barbour, Rosanna Coppo, Jonathan Barratt, Lee Er, Richard Lafayette, Vivekanand Jha

Kidney Int Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroid Effects in IgA Nephropathy by Baseline Proteinuria and Estimated GFR.
Dana Kim, Brendon L Neuen, Jicheng Lv, Michelle A Hladunewich, Vivekanand Jha

Kidney Int Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis